共 13 条
[1]
Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier(Imiquimod) in genital warts. ARANY I,TYRING SK,BRYSK MM,et al. Antimicrobial Agents and Chemotherapy . 2000
[2]
The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6. BOTTREL RL,YANG YL,LEVY DE,et al. Antimicrobial Agents and Chemotherapy . 1999
[3]
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. GILSON RJ,SHUPACK JL,FRIEDMAN-KIEN AE,et al. AIDS . 1999
[4]
A randomized,controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. TYRING SK,ARANY I,STANLEY MA,et al. The Journal of Infectious Diseases . 1998
[5]
Treatment of genital warts with an immune-response modifier ( imiquimod). BEUTNER KR,SPRUANCE SL,HOUGHAM AJ,et al. Journal of the American Academy of Dermatology . 1998
[6]
Therapeutic approaches to genital warts. BEUTNER KR,FERENCZY A. The American Journal of Medicine . 1997
[7]
DRUGS[P]. HIDAKA HIROYOSHI;TAKAGI MANABU;MATSUZAKI TAKUSHI.WO9964011A1,1999-12-16
[8]
Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. ARANY I,TYRING SK,STANLEY MA,et al. Antiviral Research . 1999
[9]
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. BEUTNER KR,TYRING SK,TROFATTER KF Jr,et al. Antimicrob Agents Chermther . 1998
[10]
Imiquimod in clinical practice. EDWARDS L. Aust Dermatol,1998 .